Oliveira M, Falato C, Cejalvo JM, Vila MM, et al. Patritumab Deruxtecan in Untreated Hormone Receptor-Positive/HER2-Negative Early Breast Cancer: Final Results from Part A of the Window-of-Opportunity SOLTI TOT-HER3 Pre-Operative Study. Ann Oncol 2023 May 19:S0923-7534(23)00685-3. doi: 10.1016/j.annonc.2023.
PMID: 37211044